His primary areas of study are Internal medicine, Cardiology, Coronary artery disease, Myocardial infarction and Genome-wide association study. His Internal medicine study frequently draws connections between adjacent fields such as Endocrinology. His Cardiology research is multidisciplinary, incorporating elements of Biomarker, Proportional hazards model and Cohort.
His Coronary artery disease research integrates issues from Immunology, Disease, Heart disease, Haplotype and C-reactive protein. His Myocardial infarction research incorporates themes from Percutaneous and Shock. The concepts of his Genome-wide association study study are interwoven with issues in Coronary atherosclerosis, Allele and Genetic association.
Stefan Blankenberg spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Surgery and In patient. Coronary artery disease, Heart failure, Hazard ratio, Troponin I and Acute coronary syndrome are the core of his Internal medicine study. His Hazard ratio study improves the overall literature in Confidence interval.
Stefan Blankenberg has researched Cardiology in several fields, including Proportional hazards model and Cohort. The study incorporates disciplines such as Prospective cohort study, Emergency department and Chest pain in addition to Myocardial infarction. His study in MitraClip, Mitral valve, Heart valve, Regurgitation and Aortic valve is done as part of Surgery.
His primary areas of investigation include Internal medicine, Cardiology, Myocardial infarction, In patient and Cohort. His Hazard ratio, Heart failure, Proportional hazards model, Coronary artery disease and Acute coronary syndrome investigations are all subjects of Internal medicine research. His study in Ejection fraction, Atrial fibrillation, Stenosis, Cardiogenic shock and Cardiac troponin falls within the category of Cardiology.
The Cardiogenic shock study combines topics in areas such as Circulatory system and Extracorporeal membrane oxygenation. His Myocardial infarction study integrates concerns from other disciplines, such as Plasminogen activator, Emergency department and Urokinase. Stefan Blankenberg interconnects Odds ratio and Interquartile range in the investigation of issues within Confidence interval.
Stefan Blankenberg mainly focuses on Internal medicine, Cardiology, Myocardial infarction, In patient and Cohort. His research in Hazard ratio, Cohort study, Cardiogenic shock, Interquartile range and Proportional hazards model are components of Internal medicine. His work deals with themes such as Plasminogen activator, Emergency department and Urokinase, which intersect with Myocardial infarction.
His Cohort study combines topics from a wide range of disciplines, such as Percentile, Disease, Cholesterol, Biomarker and Reference values. His study in Troponin is interdisciplinary in nature, drawing from both Troponin I and Cardiac troponin. Within one scientific family, Stefan Blankenberg focuses on topics pertaining to Troponin C under Receptor, and may sometimes address concerns connected to Coronary artery disease.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genomewide association analysis of coronary artery disease.
Nilesh J. Samani;Jeanette Erdmann;Alistair S. Hall;Christian Hengstenberg.
The New England Journal of Medicine (2007)
Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction
Till Keller;Tanja Zeller;Dirk Peetz;Stergios Tzikas.
The New England Journal of Medicine (2009)
Large-scale association analysis identifies new risk loci for coronary artery disease
Panos Deloukas;Stavroula Kanoni;Christina Willenborg;Martin Farrall.
Nature Genetics (2013)
Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies
Muredach P Reilly;Mingyao Li;Jing He;Jane F Ferguson.
The Lancet (2011)
Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study.
Renate Schnabel;Stefan Blankenberg;Edith Lubos;Karl J. Lackner.
Circulation Research (2005)
Repeated Replication and a Prospective Meta-Analysis of the Association Between Chromosome 9p21.3 and Coronary Artery Disease
Heribert Schunkert;Anika Götz;Peter Braund;Ralph McGinnis.
Circulation (2008)
Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction.
Till Keller;Tanja Zeller;Francisco Ojeda;Stergios Tzikas.
JAMA (2011)
Impact of infectious burden on extent and long-term prognosis of atherosclerosis.
Christine Espinola-Klein;Hans J. Rupprecht;Stefan Blankenberg;Christoph Bickel.
Circulation (2002)
CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-α levels
Axel Schlitt;Gunnar H. Heine;Stefan Blankenberg;Christine Espinola-Klein.
Thrombosis and Haemostasis (2004)
Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA
Johannes Kettunen;Ayşe Demirkan;Ayşe Demirkan;Peter Würtz;Harmen H M Draisma.
Nature Communications (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Universität Hamburg
Johannes Gutenberg University of Mainz
University of Cologne
Finnish Institute for Health and Welfare
Johannes Gutenberg University of Mainz
Finnish Institute for Health and Welfare
Sorbonne University
Finnish Institute for Health and Welfare
University of Ulm
Johannes Gutenberg University of Mainz
Florida Institute for Human and Machine Cognition
Georgia Institute of Technology
Chung-Ang University
Centre national de la recherche scientifique, CNRS
University of Notre Dame
Purdue University West Lafayette
Cornell University
University of Southampton
University of California, Riverside
University of California, Los Angeles
Boston Children's Hospital
University of Technology Sydney
University Medical Center Groningen
Wake Forest University
Samsung Medical Center
University of Southern California